renal

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

Anticoagulation in Pregnant Women: Which Medications are Safe?

By: Diana Gritsenko, PharmD Candidate 2015 - Multiple complications can arise during pregnancy. While venous thromboembolism (VTE) has a prevalence…

12 years ago

New Strides in Lupus Treatment

By: Daniel Mathan, PharmD Candidate c/o 2016, Anita Kachappilly, PharmD Candidate c/o 2016, & Amrita Singh, PharmD Candidate c/o 2015 -…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

The Importance of Organ Donation: Perspectives and the Lives Affected

By: James Schurr, PharmD Candidate c/o 2014 and Jennifer Miao, PharmD Candidate c/o 2014 With very special thanks to Jessica…

12 years ago

Say Hello to JNC8: New Hypertension Guidelines

By: Frances Trosa PharmD Candidate c/o 2015 - After much anticipation, the report from the Eighth Joint National Committee (JNC…

12 years ago

Direct Association of HIV and Early Kidney Damage in Women

By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC - Human immunodeficiency virus (HIV)…

12 years ago

Ceftriaxone Induced Hemolytic Anemia

By: Samad Tirmizi, PharmD Candidate c/o 2014 - Hemolytic anemia (HA) is a type of anemia that occurs due to…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

Understanding Opioid Overdose

By: Aleena Cherian, PharmD Candidate c/o 2014 - Although opioid analgesics are among the most effective drugs to treat pain,…

13 years ago

New FDA Approval: Fycompa® to Treat Seizures

By: Bhavini Shah, PharmD Candidate c/o 2013  - Fycompa® (perampanel) has received the U.S. Food and Drug Administration (FDA) approval…

13 years ago

Liraglutide (Victoza®) for Type 2 Diabetes Mellitus

By:  Miriam Maltz, PharmD Candidate c/o 2013, AMSCOP, Long Island University - Type 2 diabetes mellitus (T2DM) is a metabolic…

13 years ago

Mechanisms of NSAID Induced Functional Renal Toxicity

By: James W.  Schurr & Stephen Argiro, PharmD Candidates c/o 2014 - Patients frequently utilize non-steroidal anti-inflammatory drugs (NSAIDs) for…

14 years ago

Medications Causing Body Temperature Fluctuations

By: Elsa Thomas, Pharm.D. c/o 2013 - Human body uses various complex mechanisms to maintain its body temperature within a…

14 years ago

Indications for Dialysis: A Mnemonic And Explanation

By: Neal Shah, Co-Editor-in-Chief -  Dialysis is the removal of substances from intravascular circulation by filtration.1  Typically, dialysis is ordered…

14 years ago

Meet the new Beta 3 Agonist: Mirabegron (Myrbetriq®)

By: Steve P. Soman - Mirabegron (Mybetriq®), known also by the brand name Betanis®in Japan, is a new once daily…

14 years ago

The Role of N-Acetylcysteine in Contrast Induced Nephropathy

By: Neal Shah, Co-Editor-In-Chief - Contrast dyes enhance imaging for computer tomography (CT), magnetic resonance (MR), and X-rays.1  Dyes usually…

14 years ago

Understanding Diabetic Ketoacidosis

By: Mohamed Dungersi, Associate Student Editor -  What is diabetic ketoacidosis (DKA)? Diabetic ketoacidosis (DKA) is an acute complication of…

14 years ago

A Reflection of my Palliative Care Rotation

By: Stanley Saji, Pharm.D. Candidate c/o 2013 - I had a preconceived notion that advanced pharmacy practice experiences (APPEs) were…

14 years ago

Proton Pump Inhibitor Use and Complications

By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 - We see proton pump inhibitors (PPIs) used in many medication regimens, but…

14 years ago

Korlym® For Endogenous Cushing’s Syndrome

By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 - On February 17, 2012, the US Food and Drug Administration (FDA) approved…

14 years ago

CHF, a Rare but Serious Presentation of Graves’ disease

By: James Schurr, Pharm.D. Candidate c/o 2014 - Graves’ disease is an autoimmune disorder that results in a state of…

14 years ago

New Oral Direct Thrombin Inhibitors and Factor Xa Anticoagulants

By: Neal Shah - Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein…

14 years ago

Clevidipine in the Management of Hypertensive Emergency

By: Neal Shah - Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than…

14 years ago

Xigris: A Worldwide Withdrawal

By: Khilna Patel, Pharm.D. Candidate c/o 2012 - On October 25 of this year, Eli Lilly and Company announced a…

14 years ago

Ivabradine: A Novel I(f) Blocker for Stable Angina

By: Neal Shah - Part I:              Preface. Part II:             Brief review of cardiac electrophysiology. Part III:           Ivabradine as a novel…

15 years ago

HIV Transmitted from a Living Organ Donor: NYC, 2009

By: Alisha Kumar, PharmD Candidate c/o 2012 - HIV transmission via organ transplantation is rare in the United States. However,…

15 years ago